Literature DB >> 6251941

Clinical and morphological features of gold neuropathy.

S M Katrak, M Pollock, C P O'Brien, H Nukada, S Allpress, C Calder, D G Palmer, D M Grennan, P L McCormack, M R Laurent.   

Abstract

Three cases of gold-related neuropathy are reported. Clinical features include an acute, symmetrically progressive polyneuropathy, focal or generalized myokymia and a tendency for initial neurological deterioration followed by improvement, after cessation of chrysotherapy. The degree of clinical recovery related to maximal disability. Morphological findings on sural nerve biopsies revealed both axonal degeneration and segmental remyelination. Similar peripheral nerve histology was seen in a parallel animal study in which the severity of the neuropathy was dose-related.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251941     DOI: 10.1093/brain/103.3.671

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  4 in total

Review 1.  Combination therapy for autoimmune diseases: the rheumatoid arthritis model.

Authors:  N Fathy; D E Furst
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Guillain-Barré syndrome following zimeldine treatment.

Authors:  J Fagius; P O Osterman; A Sidén; B E Wiholm
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

3.  Gold toxicity presenting as peripheral neuropathy.

Authors:  J J Weiss; G R Thompson; R Lazaro
Journal:  Clin Rheumatol       Date:  1982-12       Impact factor: 2.980

4.  The syndrome of continuous muscle fibre activity following gold therapy.

Authors:  W Grisold; B Mamoli
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.